Diploma (DPLM) Trading update summary
Event summary combining transcript, slides, and related documents.
Trading update summary
18 Mar, 2026Upgraded guidance and financial performance
Organic growth guidance raised to 9% for FY26, with acquisitions contributing 3% and margins increased to approximately 25%, implying a 13% uplift to consensus operating profit.
Earnings expected to rise over 20% for the year, supported by strong returns on capital and sustainable compounding.
First half performance is exceptionally strong, with high single-digit growth excluding Peerless and double-digit growth in IS Group and Clarendon.
Eight acquisitions completed in the last two quarters for around GBP 130 million, adding about GBP 20 million in annualised operating profit, with a healthy short-term pipeline.
Strong trading momentum continues, with confidence in H2 performance.
Business and segment highlights
Controls segment sees robust growth, especially in aerospace, energy, defence, and datacentres, with IS Group and Clarendon delivering double-digit growth and margin improvements.
Peerless continues to outperform, with sustainable market dynamics and ongoing market share gains.
North American Seals shows strong core growth, supported by infrastructure and nuclear sectors, while international performance, especially UK, remains challenging.
Life Sciences achieves mid-single-digit growth and share gains in MedTech and IVD in the UK and Ireland, with expanding margins.
Windy City benefits from data center and distributed antenna system demand, maintaining strong momentum.
Market and operational outlook
Market demand remains strong and consistent, with favorable dynamics and a significant backlog in new builds and refurbishments.
Supply chain constraints persist, with no expected near-term changes.
Defense exposure is growing, supported by new investments, a Czech Republic facility, and bolt-on acquisitions like Spring Solutions.
Pricing inflation from energy costs is minimal and patchy, with the group well-positioned to manage any increases.
Organic growth is primarily volume-driven, with pricing playing a lesser role.
Latest events from Diploma
- Q3 saw 13% revenue growth, 20.5% margin, and 15% EPS growth expected for the year.DPLM
Q3 2024 TU3 Feb 2026 - Q1 saw 14% organic growth, four acquisitions, and steady margins, with guidance reaffirmed.DPLM
Q1 2026 TU14 Jan 2026 - Strong revenue and EPS growth, margin expansion, and robust FY25 outlook.DPLM
H2 202413 Jan 2026 - Q1 organic revenue up 7%, reported revenue up 12%, with strong margins and stable outlook.DPLM
Q1 2025 TU10 Jan 2026 - Earnings up 23% with 14% revenue growth, upgraded guidance, and robust segment performance.DPLM
H1 202519 Nov 2025 - Double-digit growth, margin expansion, and robust FY26 outlook driven by organic and acquisition gains.DPLM
H2 202518 Nov 2025 - Upgraded growth guidance, strong results, and two strategic acquisitions support positive outlook.DPLM
Trading Update14 Oct 2025